Want to join the conversation?
Under $MNK's acquire to invest operating model, it will invest in market development of Recothrom, PreveLeak and Raplixa, all innovative, highly durable hemostasis products that increase surgeons' choices. The addition of these global hemostasis assets to its Specialty Brands segment will expand $MNK's growing hospital portfolio.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.